Related Experiment Video
Updated: Mar 22, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Microrna-199a-5p Functions as a Tumor Suppressor via Suppressing Connective Tissue Growth Factor (CTGF) in Follicular
Abstract:
BACKGROUND The objective of this study was to explore the role of miR-199a-5p in the development of thyroid cancer, including its anti-proliferation effect and downstream signaling pathway. MATERIAL AND METHODS We conducted qRT-PCR analysis to detect the expressions of several microRNAs in 42 follicular thyroid carcinoma patients and 42 controls. We identified CTGF as target of miR-491, and viability and cell cycle status were determined in FTC-133 cells transfected with CTGF siRNA, miR-199a mimics, or inhibitors. RESULTS We identified an underexpression of miR-199a-5p in follicular thyroid carcinoma tissue samples compared with controls. Then we confirmed CTGF as a target of miR-199a-5p thyroid cells by using informatics analysis and luciferase reporter assay. Additionally, we found that mRNA and protein expression levels of CTGF were both clearly higher in malignant tissues than in benign tissues. miR-199a-5p mimics and CTGF siRNA similarly downregulated the expression of CTGF, and reduced the viability of FTC-133 cells by arresting the cell cycle in G0 phase. Transfection of miR-199a-5p inhibitors increased the expression of CTGF and promoted the viability of the cells by increasing the fraction of cells in G2/M and S phases. CONCLUSIONS Our study proves that the CTGF gene is a target of miR-199a-5p, demonstrating the negatively related association between CTGF and miR-199a. These findings suggest that miR-199a-5p might be a novel therapeutic target in the treatment of follicular thyroid carcinoma.
Insights
MicroRNA-199a-5p is underexpressed in follicular thyroid carcinoma. This microRNA targets CTGF, inhibiting cancer cell proliferation and suggesting miR-199a-5p as a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Follicular thyroid carcinoma (FTC) is a common endocrine malignancy.
- Understanding the molecular mechanisms driving FTC development is crucial for effective treatment.
Purpose of the Study:
- To investigate the role of microRNA-199a-5p (miR-199a-5p) in follicular thyroid carcinoma.
- To identify downstream signaling pathways regulated by miR-199a-5p.
- To explore the anti-proliferative effects of miR-199a-5p in thyroid cancer cells.
Main Methods:
- Quantitative reverse transcription polymerase chain reaction (qRT-PCR) to assess microRNA expression in patient samples.
- Bioinformatic analysis and luciferase reporter assays to identify and validate miR-199a-5p targets.
- Cell viability assays and cell cycle analysis in FTC-133 cells following transfection with miR-199a-5p mimics, inhibitors, or CTGF siRNA.
Main Results:
- miR-199a-5p was significantly underexpressed in follicular thyroid carcinoma tissues compared to controls.
- Connective tissue growth factor (CTGF) was confirmed as a direct target of miR-199a-5p.
- CTGF mRNA and protein levels were elevated in malignant thyroid tissues.
- miR-199a-5p mimics and CTGF siRNA reduced cell viability by inducing G0 cell cycle arrest.
- miR-199a-5p inhibition increased CTGF expression and promoted cell proliferation via G2/M and S phase progression.
Conclusions:
- CTGF is a validated downstream target of miR-199a-5p in thyroid cancer.
- A negative regulatory relationship exists between miR-199a-5p and CTGF.
- miR-199a-5p demonstrates potential as a novel therapeutic target for follicular thyroid carcinoma treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions

